Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Taking Egrifta and getting CoolSculpt: Is this a midlife crisis or a healthy reality?
The drug Egrifta (tesamorelin), developed as a treatment for excess abdominal fat in people with HIV, may have an additional benefit of promot...
The injectable drug Egrifta (tesamorelin) led to modest drops in abdominal and liver fat levels in a preliminary study of people with HIV.
Egrifta (tesamorelin), a drug approved to reduce gut fat accumulation, also reduces cellular inflammation.
HIV-positive individuals experiencing a loss of muscle mass and an increase in abdominal fat may face an increased risk of death, according to...
Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy, according to a November 10 announcement from...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.